Jerusalem – Israeli doctors have developed an innovative medicine for heart failure, Kaplan Medical Centre in Central Israel reported on Tuesday.
Heart failure is a state in which the heart activity fails to the point of shortness of breath and edema, the most common cause of mortality and hospitalisations over the age of 65.
For many years, cardiac amyloidosis, like Alzheimer’s’, has been considered an incurable disease.
Their study, including successful animal experiments was published in the European Heart Journal.
The new drug is an antibody that activates the immune system cells in the heart, so they will swallow and break down the amyloid protein that accumulates in the heart.
This way, thus the cardiac muscle cells are protected and return to normal functioning.
The next step, according to the researchers, is to apply these findings to the treatment of heart failure patients with amyloidosis background. (Xinhua/NAN)